Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3–dependent sensitization
- Creators
- Jurczak, Alexandra
- Delay, Lauriane
- Barbier, Julie
- Simon, Nils
- Krock, Emerson
- Sandor, Katalin
- Agalave, Nilesh
- Rudjito, Resti
- Wigerblad, Gustaf
- Rogóż, Katarzyna
- Briat, A.
- Miot-Noirault, Elisabeth
- Martinez-Martinez, Arisai
- Brömme, Dieter
- Grönwall, Caroline
- Malmström, Vivianne
- Klareskog, Lars
- Khoury, Spiro
- Ferreira, Thierry
- Labrum, Bonnie
- Deval, Emmanuel
- Jiménez-Andrade, Juan Miguel
- Marchand, Fabien
- Svensson, Camilla
- Others:
- Karolinska Institutet [Stockholm]
- Neuro-Dol (Neuro-Dol) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)
- Imagerie Moléculaire et Stratégies Théranostiques (IMoST) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)
- Universidad Autónoma de Tamaulipas ; Universidad Autónoma de Tamaulipas
- University of British Columbia [Vancouver]
- Karolinska University Hospital [Stockholm]
- Lipotoxicity and Channelopathies - ConicMeds (LitCh) ; Signalisation et Transports Ioniques Membranaires (STIM) ; Université de Poitiers-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS)
- Institut de pharmacologie moléculaire et cellulaire (IPMC) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA)
Description
Several bone conditions, eg, bone cancer, osteoporosis, and rheumatoid arthritis (RA), are associated with a risk of developing persistent pain. Increased osteoclast activity is often the hallmark of these bony pathologies and not only leads to bone remodeling but is also a source of pronociceptive factors that sensitize the bone-innervating nociceptors. Although historically bone loss in RA has been believed to be a consequence of inflammation, both bone erosion and pain can occur years before the symptom onset. Here, we have addressed the disconnection between inflammation, pain, and bone erosion by using a combination of 2 monoclonal antibodies isolated from B cells of patients with RA. We have found that mice injected with B02/B09 monoclonal antibodies (mAbs) developed a long-lasting mechanical hypersensitivity that was accompanied by bone erosion in the absence of joint edema or synovitis. Intriguingly, we have noted a lack of analgesic effect of naproxen and a moderate elevation of few inflammatory factors in the ankle joints suggesting that B02/B09-induced pain-like behavior does not depend on inflammatory processes. By contrast, we found that inhibiting osteoclast activity and acid-sensing ion channel 3 signaling prevented the development of B02/B09-mediated mechanical hypersensitivity. Moreover, we have identified secretory phospholipase A2 and lysophosphatidylcholine 16:0 as critical components of B02/B09-induced pain-like behavior and shown that treatment with a secretory phospholipase A2 inhibitor reversed B02/B09-induced mechanical hypersensitivity and bone erosion. Taken together, our study suggests a potential link between bone erosion and pain in a state of subclinical inflammation and offers a step forward in understanding the mechanisms of bone pain in diseases such as RA.
Abstract
International audience
Additional details
- URL
- https://hal.science/hal-04061760
- URN
- urn:oai:HAL:hal-04061760v1
- Origin repository
- UNICA